# Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone

> **NCT00244023** · PHASE3 · COMPLETED · sponsor: **SELARL du Dr Jacques BUVAT** · enrollment: 173 (actual)

## Conditions studied

- Erectile Dysfunction
- Hypogonadism

## Interventions

- **DRUG:** Testosterone gel
- **DRUG:** testosterone
- **OTHER:** placebo gel

## Key facts

- **NCT ID:** NCT00244023
- **Lead sponsor:** SELARL du Dr Jacques BUVAT
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-10
- **Primary completion:** 2007-07
- **Final completion:** 2007-07
- **Target enrollment:** 173 (ACTUAL)
- **Last updated:** 2008-08-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00244023

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00244023, "Co-Administering Testosterone With PDE5 Inhibitors in ED Patients Non Responders to PDE5 Inhibitors Alone". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00244023. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*